Sage Journals: Discover world-class research

Free access

Research article

First published 2008-10

Histopathology of the Urinary Bladders of Cynomolgus Monkeys Treated with PPAR Agonists

Jerry F. Hardisty, Daniel C. Anderson, Scott Brodie [...]

Toxicologic Pathology

Free access

Research article

First published 2007-12

Histopathology Of Hemangiosarcomas in Mice and Hamsters and Liposarcomas/Fibrosarcomas in Rats Associated with PPAR Agonists

Jerry F. Hardisty, Michael R. Elwell, Heinrich Ernst [...]

Toxicologic Pathology

Open access

Research article

First published 2025

Efficacy and safety of PPAR agonists in primary biliary cholangitis: a systematic review and meta-analysis

Wanying Liao, Siyang Fu, Aiming Yang [...]

Therapeutic Advances in Gastroenterology

Free access

Research article

First published 2012-4

Peroxisome proliferator-activated receptor (PPAR α/γ) agonists as a potential target to reduce cardiovascular risk in diabetes

Stephen J Nicholls, Kiyoko Uno

Diabetes & Vascular Disease Research

Free access

Research article

First published 2017-3

A PPAR-gamma agonist protects from radiation-induced intestinal toxicity

Monica Mangoni, Mariangela Sottili, Chiara Gerini [...]

United European Gastroenterology Journal

Retricted access

Research article

First published 2010-5

Strategies for the development of new PPAR agonists in diabetes

Matthew A. Cavender, Stephen J. Nicholls, Lincoff A. Michael

European Journal of Preventive Cardiology

Open access

Research article

First published 2017-8

PPAR-δ Agonist With Mesenchymal Stem Cells Induces Type II Collagen-Producing Chondrocytes in Human Arthritic Synovial Fluid

Bruce E. Heck, Joshua J. Park, Vishruti Makani [...]

Cell Transplantation

Free access

Research article

First published 2009-10

Neoplastic and Non-neoplastic Changes in F-344 Rats Treated with Naveglitazar,a γ-Dominant PPAR α/γ Agonist

Gerald G. Long, Vincent L. Reynolds, L. Wayne Dochterman [...]

Toxicologic Pathology

Free access

Research article

First published 2008-2

Urothelial Carcinogenesis in the Urinary Bladder of Rats Treated with Naveglitazar,a γ-dominant PPAR α/γ Agonist: Lack of Evidence for Urolithiasis as an Inciting Event

Gerald G. Long, Vincent L. Reynolds, Alric Lopez-Martinez [...]

Toxicologic Pathology

Retricted access

Research article

First published 2014-1

Fenofibrate vs pioglitazone: Comparative study of the anti-arthritic potencies of PPAR-alpha and PPAR-gamma agonists in rat adjuvant-induced arthritis

Meriem Koufany, Jean-Yves Jouzeau, David Moulin

Bio-Medical Materials and Engineering

Search results